Biomarkers · Liver & Nutritional
Gamma-Glutamyl Transferase (GGT)
Lower values go with lower risk of death. In NHANES 1999–2018 with linked mortality to 2019, each standard deviation above average goes with 26% higher risk of death. We found the same pattern in NHANES
GGT and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to each curve's own reference value, so the two curves need not cross 1 at the same point. The dotted vertical line marks the NHANES median.
GGT by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 8.00 | 13.0 | 18.0 | 29.0 | 71.0 | 1,431 | NHANES 2017-2018 |
| All | 40-59 | 10.0 | 15.0 | 22.0 | 37.0 | 96.3 | 1,547 | NHANES 2017-2018 |
| All | 60+ | 9.00 | 14.0 | 20.0 | 29.0 | 72.4 | 1,890 | NHANES 2017-2018 |
| All | all | 9.00 | 14.0 | 20.0 | 31.0 | 80.0 | 4,868 | NHANES 2017-2018 |
| Men | 20-39 | 11.0 | 16.7 | 24.0 | 35.0 | 102 | 684 | NHANES 2017-2018 |
| Men | 40-59 | 13.0 | 20.0 | 26.0 | 43.0 | 107 | 722 | NHANES 2017-2018 |
| Men | 60+ | 11.0 | 16.0 | 24.0 | 34.0 | 83.3 | 958 | NHANES 2017-2018 |
| Men | all | 11.0 | 17.9 | 25.0 | 40.0 | 102 | 2,364 | NHANES 2017-2018 |
| Women | 20-39 | 8.00 | 10.5 | 14.0 | 21.0 | 47.6 | 747 | NHANES 2017-2018 |
| Women | 40-59 | 8.00 | 13.0 | 18.0 | 27.0 | 64.8 | 825 | NHANES 2017-2018 |
| Women | 60+ | 9.00 | 14.0 | 18.0 | 26.0 | 53.0 | 932 | NHANES 2017-2018 |
| Women | all | 8.00 | 12.0 | 17.0 | 25.0 | 58.0 | 2,504 | NHANES 2017-2018 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in GGT, study by study
3 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| behavioral | Cessation of alcohol intake (supervised abstinence) | Elevated GGT usually normalised within 1 to 3 weeks of supervised abstinence in alcohol-dependent patients (12 patients) | case series | Helander A, et al. Carbohydrate-deficient transferrin and gamma-glutamyl… |
| diet | Regular coffee consumption (≥3 cups/day) | ≥3 cups/day coffee associated with lower odds of abnormal GGT (OR 0.69; 95% CI 0.57-0.83) vs none, and lower continuous GGT | cross-sectional | Xiao Q, et al. Inverse associations of total and decaffeinated coffee with… |
| pharmacologic | Once-weekly subcutaneous tirzepatide 15 mg for 72 weeks in adults with obesity without diabetes | GGT geometric mean -32.7% vs placebo at 72 weeks (5 mg -18.6%, 10 mg -21.6%) | RCT | Sattar N, et al. J Am Coll Cardiol. 2026. Comprehensive Long-Term Changes in… |
| pharmacologic | Elafibranor 80 mg once daily for 12 weeks in PBC with incomplete response to ursodeoxycholic acid | GGT -37.0% (SD 25.5) at 12 weeks vs +0.2% with placebo | RCT | Schattenberg JM, et al. J Hepatol. 2021. A randomized placebo-controlled trial… |
| supplement | Soluble fiber supplementation (0.0025-40 g/day, 3-52 weeks); effect per 5 g/day increment | No effect on GGT: MD 0.12 U/L (95% CI -0.81 to 1.05) per 5 g/day soluble fiber | meta-analysis | Ghavami A, et al. Int J Vitam Nutr Res. 2024. No benefit of soluble fiber on… |
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| diet | Chronic heavy alcohol consumption | GGT significantly higher in heavy drinkers than moderate drinkers or abstainers; 62% of heavy drinkers had elevated GGT | cross-sectional | Alatalo P, et al. Biomarkers of liver status in heavy drinkers, moderate… |
| pharmacologic | Enzyme-inducing anticonvulsants (Phenytoin, Carbamazepine, Phenobarbital) | Enzyme-inducing anticonvulsants raise serum GGT; drug score correlated with total GGT (r=0.382) in 90 treated patients | cross-sectional | Tutor-Crespo M, et al. Isoforms of serum gamma-glutamyltransferase in epileptic… |
Sources
- Risk curve: Kunutsor SK 2014 (PMID 24585856): all-cause RR 1.07 (1.04-1.1) per 5 U/l increment in GGT. Scaled to US values (NHANES).
- Kunutsor SK, Apekey TA, Seddoh D, Walley J. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):187-201.
- NHANES curve: our Cox model adjusted for age and sex, NHANES 1999–2018 with linked mortality to 2019.
Map Gamma-Glutamyl Transferase (GGT) against another biomarker.
Related markers: Alanine Aminotransferase (ALT) · Albumin:Globulin Ratio (A/G) · Alkaline Phosphatase (ALP) · Aspartate Aminotransferase (AST) · De Ritis Ratio (AST/ALT) · FIB-4 Index (NAFLD Fibrosis Score) · Serum Albumin · Serum Total Bilirubin